For most boards, Generative AI has gone from curiosity to core conversation in record time. In this blog we explore the reasons for implementing GenAI into business.
What was once the stuff of tech conferences and pilot projects is now a standing agenda item in boardrooms across the UK and beyond. Directors are asking the right questions: Where can this technology create real value? What are the risks? And how do we keep pace without losing control?
At Trimontium, we’re seeing a clear shift. Boards are moving beyond fascination and into focus. From “what’s possible?” to “what’s valuable, manageable, and sustainable?”
The new reality: GenAI is here, and it’s scaling fast
Across industries, the pace of adoption is extraordinary. More than half of US board directors report that their companies are already piloting GenAI initiatives and nearly one in five say they’re scaling them across the enterprise.
That momentum is backed by serious money. In the next year, two-thirds of C-suite leaders plan to invest over $50 million in GenAI, particularly in governance, technology infrastructure, workforce training, and customer experience.
Boards aren’t just approving those budgets. They’re shaping the philosophy behind them, ensuring innovation is matched by responsibility.
Directors and executives: aligned on purpose, divided on outcomes
Interestingly, while both boards and executives are leaning into AI, their priorities differ slightly.
Executives see GenAI as a growth engine, a route to new products, services, and business models.
Boards, however, are more focused on efficiency and resilience, the tangible productivity gains that improve margin and mitigate risk.
Yet beneath those different emphases lies shared ground. Both agree that success depends on the same foundations: data quality, trust, cybersecurity, and disciplined risk management.
Understanding what makes GenAI different
Boards have overseen digital transformation before, ERP rollouts, automation, analytics but GenAI is something new. It’s faster, cheaper, and more democratised than any technology wave before it.
Here’s why it matters:
- Instant awareness. Employees didn’t need a training session to discover GenAI, they’ve already used it. Adoption happened organically, in months, not years.
- No massive upfront investment. The big tech players have already spent billions training large language models. Businesses can now access this power through subscription, not capital outlay.
- Human augmentation, not replacement. GenAI is most effective when it amplifies people, speeding up drafting, summarising, analysis, and ideation, freeing time for higher-value work.
- Continuous evolution. With embedded tools like Microsoft Copilot and new “large action models” on the horizon, the technology is evolving weekly. Board oversight needs to evolve just as fast.
Turning potential into measurable value
Boards are now asking a sharper question: Where does GenAI actually move the needle?
The answers are emerging fast:
- Driving productivity. Knowledge workers can reclaim hours per week, time that can be reinvested into innovation, client delivery, or strategic initiatives.
- Accelerating innovation. From faster R&D cycles to smarter customer insights, GenAI can open new routes to market.
- Scaling value capture. Leading firms are blending top-down and bottom-up adoption establishing “use-case factories” while empowering employees to experiment safely within guardrails.
- Measuring ROI. Quick wins are easy to spot, but long-term value depends on connecting GenAI to proprietary data …the engine of differentiation. That requires investment, patience, and clarity of purpose.
From hype to governance – implementing GenAI into business
The opportunity is enormous, but so is the accountability.
Boards play a critical role in ensuring GenAI’s promise doesn’t outpace its principles. That means embedding governance frameworks, ensuring data ethics, and equipping management with the right oversight structures.
At Trimontium, we believe the boards that succeed won’t be the ones that move fastest, but the ones that move smartest.
They’ll treat GenAI not as a shiny object, but as a strategic capability. They’ll balance ambition with assurance, innovation with integrity, and speed with structure.
Because when boards get GenAI right, it doesn’t just transform how a business operates.
It redefines what the business can become by implementing GenAI into business.
You may also be interested in reading Deloitte’s deep dive report to see the impact of GenAI on UK businesses.
Author: Deborah Holmwood, Client Change & Transformation Partner.
Follow our LinkedIn company page to stay up to date with all our new blogs!
